Maronpot RM - Search Results

1

Gastrointestinal hyperplasia with altered expression of DNA polymerase beta.

Yoshizawa K, Jelezcova E, Brown AR, Foley JF, Nyska A, Cui X, Hofseth LJ, Maronpot RM, Wilson SH, Sepulveda AR, Sobol RW. Yoshizawa K, et al. Among authors: maronpot rm. PLoS One. 2009 Aug 5;4(8):e6493. doi: 10.1371/journal.pone.0006493. PLoS One. 2009. PMID: 19654874 Free PMC article.

2

Furan-induced dose-response relationships for liver cytotoxicity, cell proliferation, and tumorigenicity (furan-induced liver tumorigenicity).

Moser GJ, Foley J, Burnett M, Goldsworthy TL, Maronpot R. Moser GJ, et al. Exp Toxicol Pathol. 2009 Mar;61(2):101-11. doi: 10.1016/j.etp.2008.06.006. Epub 2008 Sep 21. Exp Toxicol Pathol. 2009. PMID: 18809303

3

Alterations in thyroid function in female Sprague-Dawley rats following chronic treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Sewall CH, Flagler N, Vanden Heuvel JP, Clark GC, Tritscher AM, Maronpot RM, Lucier GW. Sewall CH, et al. Among authors: maronpot rm. Toxicol Appl Pharmacol. 1995 Jun;132(2):237-44. doi: 10.1006/taap.1995.1104. Toxicol Appl Pharmacol. 1995. PMID: 7540335

4

In vivo noninvasive detection of Brown Adipose Tissue through intermolecular zero-quantum MRI.

Branca RT, Zhang L, Warren WS, Auerbach E, Khanna A, Degan S, Ugurbil K, Maronpot R. Branca RT, et al. PLoS One. 2013 Sep 10;8(9):e74206. doi: 10.1371/journal.pone.0074206. eCollection 2013. PLoS One. 2013. PMID: 24040203 Free PMC article.

5

Role of proto-oncogene activation in carcinogenesis.

Anderson MW, Reynolds SH, You M, Maronpot RM. Anderson MW, et al. Among authors: maronpot rm. Environ Health Perspect. 1992 Nov;98:13-24. doi: 10.1289/ehp.929813. Environ Health Perspect. 1992. PMID: 1486840 Free PMC article. Review.

6

Toxicology and carcinogenesis studies of pentachlorophenol in rats.

Chhabra RS, Maronpot RM, Bucher JR, Haseman JK, Toft JD, Hejtmancik MR. Chhabra RS, et al. Among authors: maronpot rm. Toxicol Sci. 1999 Mar;48(1):14-20. doi: 10.1093/toxsci/48.1.14. Toxicol Sci. 1999. PMID: 10330679

7

Modeling the number and size of hepatic focal lesions following exposure to 2,3,7,8-TCDD.

Portier CJ, Sherman CD, Kohn M, Edler L, Kopp-Schneider A, Maronpot RM, Lucier G. Portier CJ, et al. Among authors: maronpot rm. Toxicol Appl Pharmacol. 1996 May;138(1):20-30. doi: 10.1006/taap.1996.0093. Toxicol Appl Pharmacol. 1996. PMID: 8658509

8

Molecular cloning and characterization of mouse CYP2J6, an unstable cytochrome P450 isoform.

Ma J, Bradbury JA, King L, Maronpot R, Davis LS, Breyer MD, Zeldin DC. Ma J, et al. Biochem Pharmacol. 2002 Nov 15;64(10):1447-60. doi: 10.1016/s0006-2952(02)01393-x. Biochem Pharmacol. 2002. PMID: 12417258

9

Integration of clinical and gene expression endpoints to explore furan-mediated hepatotoxicity.

Hamadeh HK, Jayadev S, Gaillard ET, Huang Q, Stoll R, Blanchard K, Chou J, Tucker CJ, Collins J, Maronpot R, Bushel P, Afshari CA. Hamadeh HK, et al. Mutat Res. 2004 May 18;549(1-2):169-83. doi: 10.1016/j.mrfmmm.2003.12.021. Mutat Res. 2004. PMID: 15120969

10

Protein tyrosine kinase inhibitors suppress the production of nitric oxide in mixed glia, microglia-enriched or astrocyte-enriched cultures.

Kong LY, McMillian MK, Maronpot R, Hong JS. Kong LY, et al. Brain Res. 1996 Aug 5;729(1):102-9. Brain Res. 1996. PMID: 8874881

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page